Molecular Imaging of Macrophages in Cardiovascular Diseases

Mol Imaging Biol. 2026 Feb 6. doi: 10.1007/s11307-026-02080-1. Online ahead of print.ABSTRACTMolecular imaging exhibits remarkable potential in immune cell tracking and advancing personalized clinical management, providing not only diagnostic and prognostic information but also enabling treatment ef

J Jia Xu

The Evolution of Cardiac Rehabilitation Since COVID-19

Heart Lung Circ. 2026 Feb 5:S1443-9506(25)01656-7. doi: 10.1016/j.hlc.2025.09.006. Online ahead of print.ABSTRACTBACKGROUND & AIM: During the COVID-19 pandemic, cardiac rehabilitation programs (CRPs) rapidly transitioned to virtual, mostly one-to-one, care. Four years later, the lasting effects on c

S Susan Marzolini

Cutaneous Vascular Tumors

Surg Pathol Clin. 2026 Mar;19(1):45-61. doi: 10.1016/j.path.2025.08.007. Epub 2025 Nov 26.ABSTRACTCutaneous vascular tumors (CVT) encompass a spectrum of benign, intermediate and malignant tumors. Classification and nomenclature of CVTs have been evolving based on emerging clinical and molecular/gen

S Swati Satturwar

Utility of Animal Models of Pneumonia and Sepsis

Clin Chest Med. 2026 Mar;47(1):105-117. doi: 10.1016/j.ccm.2025.11.005. Epub 2025 Dec 22.ABSTRACTPneumonia remains a leading cause of mortality worldwide. While infectious diseases pose a greater burden in resource-limited regions, pneumonia has the highest incidence and mortality rates among all in

H Hiroki Taenaka